产品特点
SUMMARY OF PRODUCT CHARACTERISTICS
1. NAME OF THE VETERINARY MEDICINAL PRODUCT
TIAMVET 125 mg/ml oral solution [CZ, HU,PT]
TIAMULINE SOLUTION CEVA
[FR]
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
One ml contains:
Active ingredient:
Tiamulin
101.2 mg equivalent to
Tiamulin hydrogen fumarate..................................................................125.0 mg
Excipient
Benzyl alcohol (E1519) ......................................................................... 15.0 mg
For a full list of excipients, see section 6.1
3. PHARMACEUTICAL FORM
Oral solution.
Clear colourless to pale yellow solution.
4. CLINICAL PARTICULARS
4.1 TARGET SPECIES
Chickens, turkeys and pigs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Chickens and turkeys:
Treatment and prevention of chronic respiratory disease caused by tiamuline susceptible strains :
_Mycoplasma gallisepticum_, _Mycoplasma meleagridis_.
Pigs:
Treatment of enzootic pneumonia caused by tiamulin susceptible strains : _Mycoplasma hyopneumoniae, _
_Mycoplasma hyorhinis. _
Treatment of haemorragic enteritis caused by or complicated by tiamulin susceptible strains : _Brachyspira _
_hyodysenteriae._
4.3 CONTRAINDICATIONS
Do not administer the product with monensin, salinomycin and narasin and other monovalent ionophore-
antibiotics 7 days before, during and 7 days after treatment of animals.
Do not use in animals with known hypersensitivity to tiamulin or any excipients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
For pigs: The uptake of medication by animals can be altered as a consequence of illness. For animals wi
阅读完整的文件